• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Ischemic Stroke Surgery Market Size

    ID: MRFR/HC/9493-CR
    136 Pages
    Rahul Gotadki
    October 2022

    Ischemic Stroke Surgery Market Research Report Information by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy and Angioplasty), by Product Type (Catheter, Aspiration System, Guidewire, Microcatheter and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers and Others) Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Ischemic Stroke Surgery Market Infographic
    Purchase Options

    Ischemic Stroke Surgery Size

    Ischemic Stroke Surgery Market Growth Projections and Opportunities

    The expansion of the ischemic stroke surgery market is linked to the increase in physical inactivity and sedentary lifestyles, along with the adoption and introduction of technologically advanced products, and a growing preference for minimally invasive procedures. Nevertheless, the limited availability of medical facilities in developing nations and a shortage of skilled professionals are expected to pose challenges to the market's growth.

    The surge in the ischemic stroke surgery market is influenced by several factors that play a crucial role in shaping its trajectory. One significant contributor is the escalation in physical inactivity and the prevalence of sedentary lifestyles. As more individuals engage in sedentary behaviors and lead less active lives, the risk of ischemic stroke increases. This heightened risk propels the demand for medical interventions and surgical procedures to address ischemic strokes, thus fostering the growth of the market.

    Another driving force behind the market's expansion is the adoption and introduction of technologically advanced products. As medical technology continues to evolve, new and improved surgical tools, equipment, and procedures are developed to enhance the effectiveness of ischemic stroke surgery. The integration of cutting-edge technologies not only improves the outcomes of surgical interventions but also attracts healthcare providers and patients seeking state-of-the-art solutions.

    The rising demand for minimally invasive procedures represents a significant growth factor for the ischemic stroke surgery market. Minimally invasive techniques offer several advantages, including reduced recovery times, lower risk of complications, and smaller incisions. Patients and healthcare professionals alike are increasingly opting for these procedures, contributing to the overall expansion of the ischemic stroke surgery market.

    However, despite the positive growth indicators, certain challenges are anticipated to impede the market's progress. A notable hindrance is the lack of adequate medical facilities in developing countries. In many regions with limited healthcare infrastructure, access to specialized ischemic stroke surgery services may be restricted. This geographical disparity poses a challenge to the widespread adoption of ischemic stroke surgical interventions.

    Additionally, a shortage of skilled professionals in the field of ischemic stroke surgery is identified as a potential obstacle to market growth. Surgical procedures, especially those involving critical areas such as the brain, require highly trained and experienced medical professionals. The shortage of skilled surgeons and healthcare staff may limit the availability and accessibility of ischemic stroke surgery services, particularly in regions facing workforce challenges.

    The growth of the ischemic stroke surgery market is fueled by various factors such as the increasing prevalence of sedentary lifestyles, advancements in medical technology, and the growing preference for minimally invasive procedures. These factors contribute to the demand for effective surgical interventions to address ischemic strokes. However, challenges like the limited availability of medical facilities in developing countries and a shortage of skilled professionals pose potential hurdles to the market's overall expansion. As the healthcare landscape continues to evolve, addressing these challenges will be crucial to ensuring widespread access to high-quality ischemic stroke surgery services globally.

    Ischemic Stroke Surgery Market Size Graph
    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    How Big is the Ischemic Stroke Surgery market?

    The Ischemic Stroke Surgery Market is anticipated to reach USD 6.77 billion by 2035 and register a CAGR of 6.52% during the forecast period of 2024 to 2032.

    Who are the key competitors in the market of Ischemic Stroke Surgery?

    Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany) are the key players in the market of Ischemic Stroke Surgery

    Which region is predicted to have the largest market share of Ischemic Stroke Surgery

    North America is predicted to lead the market of Ischemic Stroke Surgery

    What are the key factors driving the market of Ischemic Stroke Surgery?

    Rise in physical inactivity and sedentary lifestyles and Adoption and launch of technologically advanced products are driving the market growth

    Which factors may act as market deterrents Ischemic Stroke Surgery?

    Lack of medical facilities and Shortage of skilled professionals are the market deterrents.

    Market Summary

    As per Market Research Future Analysis, the Global Ischemic Stroke Surgery Market was valued at USD 3.84 Billion in 2023 and is projected to reach USD 6.77 Billion by 2032, growing at a CAGR of 6.52% from 2024 to 2032. The market is driven by increasing physical inactivity, the launch of advanced products, and a rising demand for minimally invasive procedures. However, challenges such as a lack of medical facilities in developing countries and a shortage of skilled professionals may hinder growth. The COVID-19 pandemic moderately disrupted production and revenue in 2020, but recovery was noted in 2021 as supply chains were restored.

    Key Market Trends & Highlights

    Key trends influencing the ischemic stroke surgery market include technological advancements and demographic shifts.

    • Market Size in 2023: USD 3.84 Billion
    • Projected Market Size by 2032: USD 6.77 Billion
    • CAGR from 2024 to 2032: 6.52%
    • Major Growth Drivers: Increase in sedentary lifestyles and demand for minimally invasive procedures

    Market Size & Forecast

    2023 Market Size USD 3.84 Billion
    2024 Projected Market Size USD 4.08 Billion
    2032 Projected Market Size USD 6.77 Billion
    CAGR (2024-2032) 6.52%

    Major Players

    Stryker (US), Medtronic Plc (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Phenox GmbH (Germany)

    Market Trends

    The Global Ischemic Stroke Surgery Market is poised for growth as advancements in surgical techniques and technologies enhance patient outcomes and recovery times.

    U.S. National Institutes of Health (NIH)

    Ischemic Stroke Surgery Market Market Drivers

    Aging Population

    The aging global population is a critical driver of the Global Ischemic Stroke Surgery Market Industry. As individuals age, the risk of ischemic stroke increases significantly due to factors such as hypertension, diabetes, and other comorbidities. This demographic shift necessitates a robust healthcare response, particularly in surgical interventions for stroke management. With a larger segment of the population requiring surgical treatment, the market is poised for growth. The projected increase in market size from 4.08 USD Billion in 2024 to 8.18 USD Billion by 2035 underscores the urgency of addressing the needs of this aging demographic.

    Growing Awareness and Education

    There is a notable increase in awareness and education regarding stroke symptoms and the importance of timely intervention, which is positively impacting the Global Ischemic Stroke Surgery Market Industry. Public health campaigns and educational programs are encouraging individuals to seek immediate medical attention when experiencing stroke symptoms. This heightened awareness leads to earlier diagnosis and treatment, which is crucial for successful surgical outcomes. As more patients become informed about their options, the demand for ischemic stroke surgeries is likely to rise, contributing to the overall growth of the market.

    Increasing Healthcare Expenditure

    The rise in global healthcare expenditure is a significant factor influencing the Global Ischemic Stroke Surgery Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to enhanced access to surgical interventions for ischemic stroke patients. This increased funding allows for the procurement of advanced surgical equipment and training for healthcare professionals. As healthcare systems prioritize stroke management, the market is expected to benefit from improved facilities and resources. This trend aligns with the projected growth of the market, reaching 4.08 USD Billion in 2024 and continuing to expand towards 8.18 USD Billion by 2035.

    Rising Incidence of Ischemic Stroke

    The increasing prevalence of ischemic stroke globally is a primary driver for the Global Ischemic Stroke Surgery Market Industry. According to health statistics, ischemic strokes account for approximately 87 percent of all strokes, leading to a growing demand for surgical interventions. As the global population ages, the incidence of ischemic strokes is projected to rise, necessitating advancements in surgical techniques and technologies. This trend is expected to contribute significantly to the market's growth, with the industry projected to reach 4.08 USD Billion in 2024 and potentially 8.18 USD Billion by 2035, reflecting a compound annual growth rate of 6.53% from 2025 to 2035.

    Technological Advancements in Surgical Procedures

    Innovations in surgical techniques and technologies are transforming the Global Ischemic Stroke Surgery Market Industry. Minimally invasive procedures, such as endovascular thrombectomy, have shown promising results in improving patient outcomes. These advancements not only enhance the efficacy of surgeries but also reduce recovery times, thereby increasing patient throughput. The integration of robotic-assisted surgery and advanced imaging techniques further supports the precision of interventions. As hospitals and surgical centers adopt these technologies, the market is likely to expand, driven by the demand for improved surgical outcomes and patient satisfaction.

    Market Segment Insights

    Regional Insights

    Key Companies in the Ischemic Stroke Surgery Market market include

    Industry Developments

      • In February 2022, Imperative Care launched the Zoom POD for stroke therapy. The Zoom POD is the world's first and only sterile field clot filtration device, allowing for speedier clot collection during essential mechanical thrombectomy treatments for patients suffering from ischemic stroke.
      • In February 2022, Johnson & Johnson Services, Inc. launched EMBOGUAR, a next-generation balloon guide catheter for use in endovascular therapies, notably those for patients suffering from acute ischemic stroke.
      • In October 2021, Phenox GmbH launched the pRESET 6-50 mechanical thrombectomy device to broaden its technological range for acute ischemic stroke across the globe.
      • In September 2021, Abbott acquired Walk Vascular, LLC (US), a medical device company with a minimally invasive mechanical aspiration system designed to remove peripheral blood clots. This acquisition will help to expand the company's peripheral vascular offerings.
      • In February 2021, Phenox GmbH expands with the creation of a new office in the UK to increase its presence in important markets around Europe.

    Future Outlook

    Ischemic Stroke Surgery Market Future Outlook

    The Ischemic Stroke Surgery Market is projected to grow at a 6.53% CAGR from 2024 to 2035, driven by advancements in surgical techniques, increasing prevalence of ischemic strokes, and enhanced healthcare infrastructure.

    New opportunities lie in:

    • Invest in AI-driven surgical tools to improve precision and outcomes.
    • Develop minimally invasive techniques to reduce recovery times and costs.
    • Expand telemedicine services for pre- and post-operative care to enhance patient access.

    By 2035, the Ischemic Stroke Surgery Market is expected to be robust, reflecting significant advancements and increased accessibility.

    Market Segmentation

    Report Overview

    North America
    • US
    • Canada

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 3.84 (USD Billion)
    Market Size 2024 4.08 (USD Billion)
    Market Size 2032 6.77 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.52 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, Rest of the World
      Key Vendors   Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany)
      Key Market Opportunities  R&D activities and investments
      Key Market Drivers  Rise in physical inactivity and sedentary lifestyles • Adoption and launch of technologically advanced products Rising demand for minimally invasive procedures

    FAQs

    How Big is the Ischemic Stroke Surgery market?

    The Ischemic Stroke Surgery Market is anticipated to reach USD 6.77 billion by 2035 and register a CAGR of 6.52% during the forecast period of 2024 to 2032.

    Who are the key competitors in the market of Ischemic Stroke Surgery?

    Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany) are the key players in the market of Ischemic Stroke Surgery

    Which region is predicted to have the largest market share of Ischemic Stroke Surgery

    North America is predicted to lead the market of Ischemic Stroke Surgery

    What are the key factors driving the market of Ischemic Stroke Surgery?

    Rise in physical inactivity and sedentary lifestyles and Adoption and launch of technologically advanced products are driving the market growth

    Which factors may act as market deterrents Ischemic Stroke Surgery?

    Lack of medical facilities and Shortage of skilled professionals are the market deterrents.

    1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
      1. | 1.1 EXECUTIVE SUMMARY
      2. | | 1.1.1 Market Overview
      3. | | 1.1.2 Key Findings
      4. | | 1.1.3 Market Segmentation
      5. | | 1.1.4 Competitive Landscape
      6. | | 1.1.5 Challenges and Opportunities
      7. | | 1.1.6 Future Outlook
    2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
      1. | 2.1 MARKET INTRODUCTION
      2. | | 2.1.1 Definition
      3. | | 2.1.2 Scope of the study
      4. | | | 2.1.2.1 Research Objective
      5. | | | 2.1.2.2 Assumption
      6. | | | 2.1.2.3 Limitations
      7. | 2.2 RESEARCH METHODOLOGY
      8. | | 2.2.1 Overview
      9. | | 2.2.2 Data Mining
      10. | | 2.2.3 Secondary Research
      11. | | 2.2.4 Primary Research
      12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
      13. | | | 2.2.4.2 Breakdown of Primary Respondents
      14. | | 2.2.5 Forecasting Model
      15. | | 2.2.6 Market Size Estimation
      16. | | | 2.2.6.1 Bottom-Up Approach
      17. | | | 2.2.6.2 Top-Down Approach
      18. | | 2.2.7 Data Triangulation
      19. | | 2.2.8 Validation
    3. SECTION III: QUALITATIVE ANALYSIS
      1. | 3.1 MARKET DYNAMICS
      2. | | 3.1.1 Overview
      3. | | 3.1.2 Drivers
      4. | | 3.1.3 Restraints
      5. | | 3.1.4 Opportunities
      6. | 3.2 MARKET FACTOR ANALYSIS
      7. | | 3.2.1 Value chain Analysis
      8. | | 3.2.2 Porter's Five Forces Analysis
      9. | | | 3.2.2.1 Bargaining Power of Suppliers
      10. | | | 3.2.2.2 Bargaining Power of Buyers
      11. | | | 3.2.2.3 Threat of New Entrants
      12. | | | 3.2.2.4 Threat of Substitutes
      13. | | | 3.2.2.5 Intensity of Rivalry
      14. | | 3.2.3 COVID-19 Impact Analysis
      15. | | | 3.2.3.1 Market Impact Analysis
      16. | | | 3.2.3.2 Regional Impact
      17. | | | 3.2.3.3 Opportunity and Threat Analysis
    4. SECTION IV: QUANTITATIVE ANALYSIS
      1. | 4.1 Healthcare, BY Type of Surgery (USD Billion)
      2. | | 4.1.1 Thrombectomy
      3. | | 4.1.2 Revascularization Surgery
      4. | | 4.1.3 Carotid Endarterectomy
      5. | | 4.1.4 Angioplasty
      6. | | 4.1.5 Others
      7. | 4.2 Healthcare, BY Product Type (USD Billion)
      8. | | 4.2.1 Catheter
      9. | | 4.2.2 Aspiration System
      10. | | 4.2.3 Guidewire
      11. | | 4.2.4 Microcatheter
      12. | | 4.2.5 Others
      13. | 4.3 Healthcare, BY End User (USD Billion)
      14. | | 4.3.1 Hospitals & Clinics
      15. | | 4.3.2 Ambulatory Surgical Centers
      16. | | 4.3.3 Others
      17. | 4.4 Healthcare, BY Region (USD Billion)
      18. | | 4.4.1 North America
      19. | | | 4.4.1.1 US
      20. | | | 4.4.1.2 Canada
      21. | | 4.4.2 Europe
      22. | | | 4.4.2.1 Germany
      23. | | | 4.4.2.2 UK
      24. | | | 4.4.2.3 France
      25. | | | 4.4.2.4 Russia
      26. | | | 4.4.2.5 Italy
      27. | | | 4.4.2.6 Spain
      28. | | | 4.4.2.7 Rest of Europe
      29. | | 4.4.3 APAC
      30. | | | 4.4.3.1 China
      31. | | | 4.4.3.2 India
      32. | | | 4.4.3.3 Japan
      33. | | | 4.4.3.4 South Korea
      34. | | | 4.4.3.5 Malaysia
      35. | | | 4.4.3.6 Thailand
      36. | | | 4.4.3.7 Indonesia
      37. | | | 4.4.3.8 Rest of APAC
      38. | | 4.4.4 South America
      39. | | | 4.4.4.1 Brazil
      40. | | | 4.4.4.2 Mexico
      41. | | | 4.4.4.3 Argentina
      42. | | | 4.4.4.4 Rest of South America
      43. | | 4.4.5 MEA
      44. | | | 4.4.5.1 GCC Countries
      45. | | | 4.4.5.2 South Africa
      46. | | | 4.4.5.3 Rest of MEA
    5. SECTION V: COMPETITIVE ANALYSIS
      1. | 5.1 Competitive Landscape
      2. | | 5.1.1 Overview
      3. | | 5.1.2 Competitive Analysis
      4. | | 5.1.3 Market share Analysis
      5. | | 5.1.4 Major Growth Strategy in the Healthcare
      6. | | 5.1.5 Competitive Benchmarking
      7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      8. | | 5.1.7 Key developments and growth strategies
      9. | | | 5.1.7.1 New Product Launch/Service Deployment
      10. | | | 5.1.7.2 Merger & Acquisitions
      11. | | | 5.1.7.3 Joint Ventures
      12. | | 5.1.8 Major Players Financial Matrix
      13. | | | 5.1.8.1 Sales and Operating Income
      14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
      15. | 5.2 Company Profiles
      16. | | 5.2.1 Medtronic (US)
      17. | | | 5.2.1.1 Financial Overview
      18. | | | 5.2.1.2 Products Offered
      19. | | | 5.2.1.3 Key Developments
      20. | | | 5.2.1.4 SWOT Analysis
      21. | | | 5.2.1.5 Key Strategies
      22. | | 5.2.2 Stryker (US)
      23. | | | 5.2.2.1 Financial Overview
      24. | | | 5.2.2.2 Products Offered
      25. | | | 5.2.2.3 Key Developments
      26. | | | 5.2.2.4 SWOT Analysis
      27. | | | 5.2.2.5 Key Strategies
      28. | | 5.2.3 Boston Scientific (US)
      29. | | | 5.2.3.1 Financial Overview
      30. | | | 5.2.3.2 Products Offered
      31. | | | 5.2.3.3 Key Developments
      32. | | | 5.2.3.4 SWOT Analysis
      33. | | | 5.2.3.5 Key Strategies
      34. | | 5.2.4 Johnson & Johnson (US)
      35. | | | 5.2.4.1 Financial Overview
      36. | | | 5.2.4.2 Products Offered
      37. | | | 5.2.4.3 Key Developments
      38. | | | 5.2.4.4 SWOT Analysis
      39. | | | 5.2.4.5 Key Strategies
      40. | | 5.2.5 Abbott Laboratories (US)
      41. | | | 5.2.5.1 Financial Overview
      42. | | | 5.2.5.2 Products Offered
      43. | | | 5.2.5.3 Key Developments
      44. | | | 5.2.5.4 SWOT Analysis
      45. | | | 5.2.5.5 Key Strategies
      46. | | 5.2.6 Terumo Corporation (JP)
      47. | | | 5.2.6.1 Financial Overview
      48. | | | 5.2.6.2 Products Offered
      49. | | | 5.2.6.3 Key Developments
      50. | | | 5.2.6.4 SWOT Analysis
      51. | | | 5.2.6.5 Key Strategies
      52. | | 5.2.7 B. Braun Melsungen AG (DE)
      53. | | | 5.2.7.1 Financial Overview
      54. | | | 5.2.7.2 Products Offered
      55. | | | 5.2.7.3 Key Developments
      56. | | | 5.2.7.4 SWOT Analysis
      57. | | | 5.2.7.5 Key Strategies
      58. | | 5.2.8 Penumbra, Inc. (US)
      59. | | | 5.2.8.1 Financial Overview
      60. | | | 5.2.8.2 Products Offered
      61. | | | 5.2.8.3 Key Developments
      62. | | | 5.2.8.4 SWOT Analysis
      63. | | | 5.2.8.5 Key Strategies
      64. | | 5.2.9 NeuroVasx, Inc. (US)
      65. | | | 5.2.9.1 Financial Overview
      66. | | | 5.2.9.2 Products Offered
      67. | | | 5.2.9.3 Key Developments
      68. | | | 5.2.9.4 SWOT Analysis
      69. | | | 5.2.9.5 Key Strategies
      70. | 5.3 Appendix
      71. | | 5.3.1 References
      72. | | 5.3.2 Related Reports
    6. LIST OF FIGURES
      1. | 6.1 MARKET SYNOPSIS
      2. | 6.2 NORTH AMERICA MARKET ANALYSIS
      3. | 6.3 US MARKET ANALYSIS BY TYPE OF SURGERY
      4. | 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
      5. | 6.5 US MARKET ANALYSIS BY END USER
      6. | 6.6 CANADA MARKET ANALYSIS BY TYPE OF SURGERY
      7. | 6.7 CANADA MARKET ANALYSIS BY PRODUCT TYPE
      8. | 6.8 CANADA MARKET ANALYSIS BY END USER
      9. | 6.9 EUROPE MARKET ANALYSIS
      10. | 6.10 GERMANY MARKET ANALYSIS BY TYPE OF SURGERY
      11. | 6.11 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
      12. | 6.12 GERMANY MARKET ANALYSIS BY END USER
      13. | 6.13 UK MARKET ANALYSIS BY TYPE OF SURGERY
      14. | 6.14 UK MARKET ANALYSIS BY PRODUCT TYPE
      15. | 6.15 UK MARKET ANALYSIS BY END USER
      16. | 6.16 FRANCE MARKET ANALYSIS BY TYPE OF SURGERY
      17. | 6.17 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
      18. | 6.18 FRANCE MARKET ANALYSIS BY END USER
      19. | 6.19 RUSSIA MARKET ANALYSIS BY TYPE OF SURGERY
      20. | 6.20 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
      21. | 6.21 RUSSIA MARKET ANALYSIS BY END USER
      22. | 6.22 ITALY MARKET ANALYSIS BY TYPE OF SURGERY
      23. | 6.23 ITALY MARKET ANALYSIS BY PRODUCT TYPE
      24. | 6.24 ITALY MARKET ANALYSIS BY END USER
      25. | 6.25 SPAIN MARKET ANALYSIS BY TYPE OF SURGERY
      26. | 6.26 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
      27. | 6.27 SPAIN MARKET ANALYSIS BY END USER
      28. | 6.28 REST OF EUROPE MARKET ANALYSIS BY TYPE OF SURGERY
      29. | 6.29 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
      30. | 6.30 REST OF EUROPE MARKET ANALYSIS BY END USER
      31. | 6.31 APAC MARKET ANALYSIS
      32. | 6.32 CHINA MARKET ANALYSIS BY TYPE OF SURGERY
      33. | 6.33 CHINA MARKET ANALYSIS BY PRODUCT TYPE
      34. | 6.34 CHINA MARKET ANALYSIS BY END USER
      35. | 6.35 INDIA MARKET ANALYSIS BY TYPE OF SURGERY
      36. | 6.36 INDIA MARKET ANALYSIS BY PRODUCT TYPE
      37. | 6.37 INDIA MARKET ANALYSIS BY END USER
      38. | 6.38 JAPAN MARKET ANALYSIS BY TYPE OF SURGERY
      39. | 6.39 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
      40. | 6.40 JAPAN MARKET ANALYSIS BY END USER
      41. | 6.41 SOUTH KOREA MARKET ANALYSIS BY TYPE OF SURGERY
      42. | 6.42 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
      43. | 6.43 SOUTH KOREA MARKET ANALYSIS BY END USER
      44. | 6.44 MALAYSIA MARKET ANALYSIS BY TYPE OF SURGERY
      45. | 6.45 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
      46. | 6.46 MALAYSIA MARKET ANALYSIS BY END USER
      47. | 6.47 THAILAND MARKET ANALYSIS BY TYPE OF SURGERY
      48. | 6.48 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
      49. | 6.49 THAILAND MARKET ANALYSIS BY END USER
      50. | 6.50 INDONESIA MARKET ANALYSIS BY TYPE OF SURGERY
      51. | 6.51 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
      52. | 6.52 INDONESIA MARKET ANALYSIS BY END USER
      53. | 6.53 REST OF APAC MARKET ANALYSIS BY TYPE OF SURGERY
      54. | 6.54 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
      55. | 6.55 REST OF APAC MARKET ANALYSIS BY END USER
      56. | 6.56 SOUTH AMERICA MARKET ANALYSIS
      57. | 6.57 BRAZIL MARKET ANALYSIS BY TYPE OF SURGERY
      58. | 6.58 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
      59. | 6.59 BRAZIL MARKET ANALYSIS BY END USER
      60. | 6.60 MEXICO MARKET ANALYSIS BY TYPE OF SURGERY
      61. | 6.61 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
      62. | 6.62 MEXICO MARKET ANALYSIS BY END USER
      63. | 6.63 ARGENTINA MARKET ANALYSIS BY TYPE OF SURGERY
      64. | 6.64 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
      65. | 6.65 ARGENTINA MARKET ANALYSIS BY END USER
      66. | 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF SURGERY
      67. | 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
      68. | 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
      69. | 6.69 MEA MARKET ANALYSIS
      70. | 6.70 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF SURGERY
      71. | 6.71 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
      72. | 6.72 GCC COUNTRIES MARKET ANALYSIS BY END USER
      73. | 6.73 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF SURGERY
      74. | 6.74 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
      75. | 6.75 SOUTH AFRICA MARKET ANALYSIS BY END USER
      76. | 6.76 REST OF MEA MARKET ANALYSIS BY TYPE OF SURGERY
      77. | 6.77 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
      78. | 6.78 REST OF MEA MARKET ANALYSIS BY END USER
      79. | 6.79 KEY BUYING CRITERIA OF HEALTHCARE
      80. | 6.80 RESEARCH PROCESS OF MRFR
      81. | 6.81 DRO ANALYSIS OF HEALTHCARE
      82. | 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
      83. | 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
      84. | 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
      85. | 6.85 HEALTHCARE, BY TYPE OF SURGERY, 2024 (% SHARE)
      86. | 6.86 HEALTHCARE, BY TYPE OF SURGERY, 2024 TO 2035 (USD Billion)
      87. | 6.87 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
      88. | 6.88 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
      89. | 6.89 HEALTHCARE, BY END USER, 2024 (% SHARE)
      90. | 6.90 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
      91. | 6.91 BENCHMARKING OF MAJOR COMPETITORS
    7. LIST OF TABLES
      1. | 7.1 LIST OF ASSUMPTIONS
      2. | | 7.1.1
      3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      4. | | 7.2.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      5. | | 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      6. | | 7.2.3 BY END USER, 2025-2035 (USD Billion)
      7. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
      8. | | 7.3.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      9. | | 7.3.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      10. | | 7.3.3 BY END USER, 2025-2035 (USD Billion)
      11. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      12. | | 7.4.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      13. | | 7.4.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      14. | | 7.4.3 BY END USER, 2025-2035 (USD Billion)
      15. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      16. | | 7.5.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      17. | | 7.5.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      18. | | 7.5.3 BY END USER, 2025-2035 (USD Billion)
      19. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      20. | | 7.6.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      21. | | 7.6.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      22. | | 7.6.3 BY END USER, 2025-2035 (USD Billion)
      23. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      24. | | 7.7.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      25. | | 7.7.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      26. | | 7.7.3 BY END USER, 2025-2035 (USD Billion)
      27. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
      28. | | 7.8.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      29. | | 7.8.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      30. | | 7.8.3 BY END USER, 2025-2035 (USD Billion)
      31. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      32. | | 7.9.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      33. | | 7.9.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      34. | | 7.9.3 BY END USER, 2025-2035 (USD Billion)
      35. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      36. | | 7.10.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      37. | | 7.10.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      38. | | 7.10.3 BY END USER, 2025-2035 (USD Billion)
      39. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      40. | | 7.11.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      41. | | 7.11.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      42. | | 7.11.3 BY END USER, 2025-2035 (USD Billion)
      43. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      44. | | 7.12.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      45. | | 7.12.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      46. | | 7.12.3 BY END USER, 2025-2035 (USD Billion)
      47. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      48. | | 7.13.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      49. | | 7.13.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      50. | | 7.13.3 BY END USER, 2025-2035 (USD Billion)
      51. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
      52. | | 7.14.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      53. | | 7.14.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      54. | | 7.14.3 BY END USER, 2025-2035 (USD Billion)
      55. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
      56. | | 7.15.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      57. | | 7.15.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      58. | | 7.15.3 BY END USER, 2025-2035 (USD Billion)
      59. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      60. | | 7.16.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      61. | | 7.16.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      62. | | 7.16.3 BY END USER, 2025-2035 (USD Billion)
      63. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      64. | | 7.17.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      65. | | 7.17.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      66. | | 7.17.3 BY END USER, 2025-2035 (USD Billion)
      67. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      68. | | 7.18.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      69. | | 7.18.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      70. | | 7.18.3 BY END USER, 2025-2035 (USD Billion)
      71. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      72. | | 7.19.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      73. | | 7.19.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      74. | | 7.19.3 BY END USER, 2025-2035 (USD Billion)
      75. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      76. | | 7.20.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      77. | | 7.20.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      78. | | 7.20.3 BY END USER, 2025-2035 (USD Billion)
      79. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      80. | | 7.21.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      81. | | 7.21.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      82. | | 7.21.3 BY END USER, 2025-2035 (USD Billion)
      83. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      84. | | 7.22.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      85. | | 7.22.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      86. | | 7.22.3 BY END USER, 2025-2035 (USD Billion)
      87. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      88. | | 7.23.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      89. | | 7.23.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      90. | | 7.23.3 BY END USER, 2025-2035 (USD Billion)
      91. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      92. | | 7.24.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      93. | | 7.24.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      94. | | 7.24.3 BY END USER, 2025-2035 (USD Billion)
      95. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      96. | | 7.25.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      97. | | 7.25.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      98. | | 7.25.3 BY END USER, 2025-2035 (USD Billion)
      99. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      100. | | 7.26.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      101. | | 7.26.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      102. | | 7.26.3 BY END USER, 2025-2035 (USD Billion)
      103. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      104. | | 7.27.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      105. | | 7.27.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      106. | | 7.27.3 BY END USER, 2025-2035 (USD Billion)
      107. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      108. | | 7.28.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      109. | | 7.28.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      110. | | 7.28.3 BY END USER, 2025-2035 (USD Billion)
      111. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      112. | | 7.29.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      113. | | 7.29.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      114. | | 7.29.3 BY END USER, 2025-2035 (USD Billion)
      115. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      116. | | 7.30.1 BY TYPE OF SURGERY, 2025-2035 (USD Billion)
      117. | | 7.30.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      118. | | 7.30.3 BY END USER, 2025-2035 (USD Billion)
      119. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
      120. | | 7.31.1
      121. | 7.32 ACQUISITION/PARTNERSHIP
      122. | | 7.32.1

    Ischemic Stroke Surgery Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions